Join
Live feed
·
PRReleasevia Quantisnow
PHAXIAM Therapeutics S.A.. logo

PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first "Phagogram Day"

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHXM (PHAXIAM Therapeutics S.A..) and more on Quantisnow.